☆ 4.7 Meeting Abstract

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 15, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Keywords

-

Categories

Oncology

Funding

  1. European Commission Framework Programme VI TRANSBIG Network of Excellence
  2. Breast Cancer Research Foundation
  3. U.S. National Cancer Institute
  4. European Breast Cancer Council
  5. Pharmaceutical/Biotech Company
  6. U.S. National Institutes of Health

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.